Performance
Trailing returns
| 1 day |
| -0.49% | |||
| 1 week | +0.16% |
| |||
| 4 week | +4.79% |
| |||
| 3 month | +6.98% |
| |||
| YTD | +11.75% |
| |||
| 1 year | +27.81% |
| |||
| 3 years* | +11.99% |
| |||
| 5 years* |
| -0.02% | |||
| *annualized | |||||
| Best 3 month return | +29.98% | |
| Worst 3 month return | -31.45% |
Morningstar statistics
Morningstar category: World Stock
| Return | Risk | Rating | |
| 3 years | Average | Below Average |
 
|
| 5 years | Below Average | Below Average |
|
| 10 years | - | - | - |
| Overall | Below Average | Below Average |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 71.65M | |
| Front load | - | |
| Deferred load | 1.00% | |
| Expense ratio | 2.10% | |
| Management fee | - | |
| Fund family | ING Funds |
Asset allocation
| Cash | 0.18% | |
| Stocks | 99.46% | |
| Bonds | 0.00% | |
| Other | 0.35% |
Purchase information
| Initial | US$1,000 | |
| IRA Initial | US$250 | |
| AIP Initial | US$1,000 | |
| AIP Additional | US$100 |
12.17-0.08(-0.65%)
May 24, 4:00PM EDT
Overall Morningstar RatingTM
Description
The investment seeks growth of capital with dividend income as a secondary consideration. The fund normally invests at least 80% of its net assets (plus borrowings for investment purposes) in a portfolio of equity securities of dividend-paying companies. It typically invests at least 65% of total assets in equities of issuers in a number of different countries, one of which may be the United States. The fund may invest in companies located in countries with emerging securities markets. It may also lend portfolio securities on a short-term or long-term basis, up to 33 1/3% of assets.
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
Nicolas Simar (Started: Jan 19, 2006)
Herman Klein (Started: Nov 23, 2010)
Bruno Springael (Started: Jun 1, 2011)
Nicolas Simar (Started: Jan 19, 2006)
Herman Klein (Started: Nov 23, 2010)
Bruno Springael (Started: Jun 1, 2011)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | -0.55 | 1.39 | -0.01 | - | |
| Beta* | 0.80 | 0.79 | 0.84 | - | |
| Mean annual return | 1.24 | 0.71 | 0.13 | - | |
| R-squared* | 96.88 | 96.21 | 93.36 | - | |
| Standard deviation | 13.24 | 15.63 | 20.29 | - | |
| Sharpe ratio | 1.11 | 0.54 | 0.06 | - | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Bristol-Myers Squibb Company (BMY) | 1.63% | |
| Microsoft Corporation (MSFT) | 1.59% | |
| General Electric Co (GE) | 1.59% | |
| MetLife Inc (MET) | 1.56% | |
| Novartis AG (NVSEF) | 1.55% | |
| Exxon Mobil Corporation (XOM) | 1.53% | |
| Freeport-McMoRan Copper & Gold Class B (FCX) | 1.49% | |
| Royal Dutch Shell PLC Class A (RYDAF) | 1.46% | |
| ArcelorMittal SA (AMSYF) | 1.43% | |
| Occidental Petroleum Corporation (OXY) | 1.41% |